We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

ProBioGen and Life Technologies Present Freedom™ CHO-S™ Platform

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

ProBioGen AG and Life Technologies Corporation announce the launch of the new Freedom™ CHO-S™ Kit as the result of a successful co-development.

The kit was built for developing stable high yield production cell lines in less than 4 months, and is based on Life Technologies’ CHO-S™ Cells.

The Freedom™ CHO-S™ Kit platform enables end-users the cost- and time-efficient creation of stable cell lines for research and commercial purposes.

The kit’s applicability and efficiency was confirmed in several studies, in which antibody titers of 1 to 3 g/L have been obtained.